re: the unloved sector - biotech I salivate when I see the AAH...

re: the unloved sector - biotech I salivate when I see the AAH chart in their presentations of the lung cancer antibody results on mice. Can't get to human trials, all going well, soon enough with that one. Although 2012 looks like a possible commercialisation year for that one so still a long way off and plenty of trials to go through.
Lots of near term potential with royalties from their work wit CSL among others, other antibody trials, and as you say a potential takeover target.

MSB is another one I'm keen on, but are 2 years away from commercialisation of their stem cells. However, if not earlier, if this years Phase 2 trials go alright there could be some interest shown by other companies like the recent Osiris deal with Genzyme.

hopefully I can get back into AAH soon with some trading profits.